5.18 Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia: Interim Results of a Phase 1–2 Study and Future Plans

✍ Scribed by Michal Haran; Alain Berrebi

• Book ID: 119218963
• Publisher: Elsevier
• Year: 2011
• Tongue: English
• Weight: 71 KB
• Volume: 11
• Category: Article
• ISSN: 2152-2650
• DOI: 10.1016/j.clml.2011.09.172